3 TSX Growth Companies With Up To 22% Insider Ownership

Over the last 7 days, the Canadian market has dropped 2.3%, driven by losses of 4.8% and 6.4%. However, in the past year, the market is up 12%, with earnings forecast to grow by 15% annually. In this context, identifying growth companies with significant insider ownership can be a strategic move for investors looking for stability and potential upside in a fluctuating market environment.

Top 10 Growth Companies With High Insider Ownership In Canada

Name	Insider Ownership	Earnings Growth
Vox Royalty (TSX:VOXR)	12.5%	70.7%
Allied Gold (TSX:AAUC)	22.5%	73.5%
Almonty Industries (TSX:AII)	17.7%	117.6%
goeasy (TSX:GSY)	21.2%	17.1%
Alvopetro Energy (TSXV:ALV)	19.4%	72.4%
Propel Holdings (TSX:PRL)	40%	37.2%
VersaBank (TSX:VBNK)	13.3%	28.2%
Medicenna Therapeutics (TSX:MDNA)	15.4%	57.2%
Alpha Cognition (CNSX:ACOG)	17.9%	69.5%
ROK Resources (TSXV:ROK)	16.6%	161.8%

Click here to see the full list of 39 stocks from our Fast Growing TSX Companies With High Insider Ownership screener.

Let's dive into some prime choices out of the screener.

Knight Therapeutics (TSX:GUD)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Knight Therapeutics Inc. develops, manufactures, acquires, licenses, markets, and distributes pharmaceutical and consumer health products as well as medical devices worldwide with a market cap of CA$570.85 million.

Operations: Revenue from pharmaceuticals amounted to CA$337.87 million.

Insider Ownership: 22.3%

Knight Therapeutics has substantial insider ownership, indicating strong internal confidence. Despite a recent net loss of CAD 1.94 million for Q2 2024, the company raised its annual revenue guidance to between CAD 355 million and CAD 365 million. The stock trades significantly below its estimated fair value, suggesting potential upside. Knight is also actively repurchasing shares, having bought back over 6 million shares recently, which may positively impact shareholder value in the long term.

• Unlock comprehensive insights into our analysis of Knight Therapeutics stock in this growth report.
• Upon reviewing our latest valuation report, Knight Therapeutics' share price might be too pessimistic.

Savaria (TSX:SIS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Savaria Corporation offers accessibility solutions for the elderly and physically challenged individuals across Canada, the United States, Europe, and internationally, with a market cap of CA$1.43 billion.

Operations: The company's revenue segments include Patient Care at CA$183.98 million and Segment Adjustment at CA$673.74 million.

Insider Ownership: 19.6%

Savaria Corporation exhibits high insider ownership, aligning with its robust growth profile. The company reported a significant earnings increase, with Q2 2024 net income rising to CAD 10.96 million from CAD 8.79 million year-over-year. Revenue is forecast to grow at 7.4% annually, outpacing the Canadian market average of 6.7%. Despite recent shareholder dilution, analysts project a stock price rise by 21.2%, and insiders have shown confidence through recent share purchases, albeit in modest volumes.

• Navigate through the intricacies of Savaria with our comprehensive analyst estimates report here.
• Our valuation report unveils the possibility Savaria's shares may be trading at a discount.

Vitalhub (TSX:VHI)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Vitalhub Corp. offers technology solutions for health and human service providers across Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally with a market cap of CA$391.57 million.

Operations: The company's revenue from healthcare software solutions amounts to CA$58.32 million.

Insider Ownership: 15.1%

Vitalhub demonstrates strong growth potential with high insider ownership. Despite recent shareholder dilution and a net loss of CAD 0.34 million in Q2 2024, revenue increased to CAD 16.24 million from CAD 13.09 million year-over-year. Analysts forecast annual revenue growth of 13.5%, outpacing the Canadian market average of 6.7%. Earnings are expected to grow significantly at an annual rate of over 65%. The stock trades at a substantial discount to its estimated fair value, with analysts predicting a price rise by approximately 25%.

• Get an in-depth perspective on Vitalhub's performance by reading our analyst estimates report here.
• Our expertly prepared valuation report Vitalhub implies its share price may be lower than expected.

Where To Now?

• Discover the full array of 39 Fast Growing TSX Companies With High Insider Ownership right here.
• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com